Related Experiment Videos
Studies on the levels and nature of cholinesterase in human and mouse placenta
Research Communications in Chemical Pathology and Pharmacology
|September 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The assessment of an in-vitro model for evaluating the role of PARP in ethanol-mediated hepatotoxicity.
International journal of critical illness and injury science·2015
Alpha1-adrenergic receptors and their significance to chemical-induced nephrotoxicity--a brief review.
Research communications in molecular pathology and pharmacology·2002
Comparison of base-excision repair capacity in proliferating and differentiated PC 12 cells following acute challenge with dieldrin.
Free radical biology & medicine·2001
Organ-specific differences in 8-oxoguanosine glycosylase (OGG1) repair following acute treatment with benzo[a]pyrene.
Research communications in molecular pathology and pharmacology·2001
Heavy metal hazards of Asian traditional remedies.
International journal of environmental health research·2001
Is heat acclimation able to increase whole-body sensitivity to insulin?
Research communications in chemical pathology and pharmacology·1994
Vasodilator effects of clonidine on the mesenteric arterial beds in normotensive and spontaneously hypertensive rats.
Research communications in chemical pathology and pharmacology·1994
Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis.
Research communications in chemical pathology and pharmacology·1994
Copper cytotoxicity impairs DNA synthesis but not protein phosphorylation upon growth stimulation in LEC mutant rat.
Research communications in chemical pathology and pharmacology·1994
Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.
Research communications in chemical pathology and pharmacology·1994
Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
Research communications in chemical pathology and pharmacology·1994